Company intelligence / Profile preview

Sartorius CellGenix

Freiburg, Baden-Württemberg, Germany

Ownership: Private
Employees: ~70
Development stage: Other

Overview

CellGenix is a leading global supplier of GMP-grade raw materials (cytokines, growth factors, serum-free media) for cell and gene therapy, with products used extensively in clinical and commercial ATMP manufacturing. CellGenix does not have therapeutics but is critical for enabling CGT clinical trials and commercial products worldwide.

Modalities: CytokineGrowth factorRecombinant proteinCell culture mediaCell therapy (enabling)
Industry: Chemicals & Materials

Partnerships

Ori Biotech (strategic partnership for closed-system manufacturing)Schering AG (historical joint venture)Saint-Gobain Life Sciences (collaboration)ISCT (collaboration)ARM (collaboration)

Beyond the preview

Go deeper on Sartorius CellGenix.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sartorius CellGenix.

Explore the full profile